Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment

Stahl, Andreas; Nakanishi, Hidehiko; Lepore, Domenico; Wu, Wei-Chi; Azuma, Noriyuki; Jacas, Carlos

View

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment, 2025 (118.9Kb)

Author

Date

2025-08

Permanent link

http://hdl.handle.net/11351/13880

DOI

10.1177/25158414251321730

ISSN

2515-8414

WOS

001484255500001

PMID

40342575

Show full item record

Keywords

Infants; Intravitreal aflibercept; Retinopathy of prematurity

Bibliographic citation

Stahl A, Nakanishi H, Lepore D, Wu WC, Azuma N, Jacas C, et al. Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment. Ther Adv Ophthalmol. 2025 Aug;17:25158414251321730.